# ETOMIDATE

NDC: 51662-1485
Generic name: ETOMIDATE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200111

FDA application: ANDA202354

## Active ingredients

- ETOMIDATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1485"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1485
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bdee875-4b48-c592-e053-2995a90a6485